Biogen Inc. Stock Price (Quote) NASDAQ:BIIB

$406.14 ( 2.40% ) Monday, 14th Jun 2021

Range	Low Price	High Price	Comment
30 days	$264.12	$468.55	Monday, 14th Jun 2021 BIIB stock ended at $406.14. This is 2.4% more than the trading day before Friday, 11th Jun 2021. During the day the stock fluctuated 3.73% from a day low at $395.14 to a day high of $409.88.
90 days	$257.03	$468.55
52 weeks	$223.25	$468.55

Historical Biogen Inc. prices

Date	Open	High	Low	Close	Volume
2021-06-14	$396.24	$409.88	$395.14	$406.14	2 100 202
2021-06-11	$423.33	$427.50	$395.33	$396.64	4 216 114
2021-06-10	$406.94	$426.82	$404.25	$414.71	4 709 693
2021-06-09	$395.00	$414.80	$390.84	$406.94	6 163 612
2021-06-08	$389.10	$399.07	$373.00	$395.37	12 198 180
2021-06-07	$295.35	$468.55	$286.00	$395.85	17 786 699
2021-06-04	$274.17	$291.71	$273.37	$286.14	2 940 482
2021-06-03	$271.49	$272.87	$266.43	$272.55	1 301 559
2021-06-02	$269.27	$271.86	$267.78	$269.35	1 181 092
2021-06-01	$272.35	$272.35	$264.12	$267.15	1 231 572
2021-05-28	$269.00	$271.99	$266.00	$267.48	952 259
2021-05-27	$269.10	$269.10	$266.00	$267.37	1 760 601
2021-05-26	$273.30	$274.35	$266.23	$267.84	1 746 237
2021-05-25	$279.96	$280.27	$272.96	$273.45	938 253
2021-05-24	$285.60	$287.27	$277.96	$278.86	833 080
2021-05-21	$288.24	$289.91	$282.78	$283.19	936 386
2021-05-20	$281.00	$290.36	$280.01	$286.57	1 047 786
2021-05-19	$278.37	$281.90	$276.07	$281.75	722 794
2021-05-18	$282.49	$283.50	$278.82	$281.01	703 671
2021-05-17	$281.17	$284.57	$279.30	$280.40	939 161
2021-05-14	$281.47	$282.09	$276.03	$280.21	990 141
2021-05-13	$274.26	$283.16	$274.26	$281.71	1 037 921
2021-05-12	$277.17	$280.69	$273.07	$274.02	922 502
2021-05-11	$274.26	$281.53	$273.50	$278.39	947 952
2021-05-10	$274.86	$278.73	$273.69	$275.61	894 514
2021-05-07	$270.66	$279.20	$270.66	$274.04	925 702
2021-05-06	$268.67	$273.03	$268.50	$272.11	928 599
2021-05-05	$271.00	$273.32	$269.47	$271.57	783 292
2021-05-04	$273.70	$273.70	$269.94	$271.02	946 821
2021-05-03	$267.87	$275.55	$267.73	$275.31	928 402
2021-04-30	$264.38	$269.71	$264.02	$267.33	892 417
2021-04-29	$268.42	$269.12	$264.40	$265.33	530 615
2021-04-28	$268.25	$270.86	$265.81	$267.60	691 753
2021-04-27	$269.07	$270.68	$265.88	$267.39	749 814
2021-04-26	$264.45	$270.49	$261.22	$269.46	1 115 728
2021-04-23	$260.33	$263.94	$258.29	$262.63	895 233
2021-04-22	$260.00	$264.52	$257.03	$259.00	2 364 133
2021-04-21	$272.63	$273.39	$266.50	$269.85	1 026 074
2021-04-20	$269.01	$274.81	$268.21	$273.20	832 813
2021-04-19	$269.55	$270.77	$265.44	$269.05	884 651
2021-04-16	$270.61	$273.83	$269.79	$270.31	1 000 008
2021-04-15	$265.71	$272.00	$265.71	$270.44	986 472
2021-04-14	$267.44	$270.38	$264.63	$265.79	697 428
2021-04-13	$264.91	$266.97	$262.42	$266.19	823 301
2021-04-12	$267.31	$268.28	$262.55	$262.80	750 272
2021-04-09	$265.73	$268.59	$263.50	$268.17	873 429
2021-04-08	$272.20	$272.20	$265.37	$265.73	794 079
2021-04-07	$272.00	$272.00	$267.18	$268.02	828 286
2021-04-06	$276.17	$276.50	$271.30	$271.76	987 409
2021-04-05	$279.24	$279.92	$276.63	$277.88	724 334

About Biogen Inc.

Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. It offers TECFIDERA, AVONEX, and PLEGRIDY to treat relapsing forms of multiple sclerosis (MS); TYSABRI to treat relapsing forms of MS and Crohns disease; and FAMPYRA to improve walking ability for patients with MS. The company also provides ELOCTATE to treat adults and children ... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!